AstraZeneca’s hopes of positioning its PD ... was no better than placebo at extending disease-free survival (DFS). The trial enrolled patients with NSCLC that had PD-L1 expression on 25% or ...

Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor ... surgery without raising the risk of bleeding events. AstraZeneca has revealed the data for Imfinzi in muscle ...

Steve Simusokwe, a young activist from Karonga, recently expressed his remorse regarding his past involvement in protests ...

Authorities in Nigeria are probing the death of 40 passengers on a boat. Local officials say the wooden boat was ferrying more than 50 farmers to their fields across the river near Gummi town in ...